ICDs (implantable cardioverter-defibrillators) are cost-effective in landmark heart failure trial:
This article was originally published in Clinica
Executive Summary
Eight months after showing that a large group of heart failure patients can live longer if they receive an implantable cardioverter-defibrillator (ICD), a landmark study has now revealed that treatment with the device is also cost-effective.